Show simple item record

ETHICS OF STEM CELL THERAPY FOR HEART FAILURE

dc.contributorNingunaes-ES
dc.contributoren-US
dc.creatorDíaz-Navarro, Rienzi; Escuela de Medicina Universidad de Valparaíso
dc.creatorPérez-Terzic, Carmen; Mayo Clinic, Rochester, MN, USA
dc.date2019-07-17
dc.date.accessioned2019-11-11T18:27:40Z
dc.date.available2019-11-11T18:27:40Z
dc.identifierhttp://www.revistamedicadechile.cl/ojs/index.php/rmedica/article/view/7497
dc.identifier.urihttps://revistaschilenas.uchile.cl/handle/2250/111251
dc.descriptionHeart failure is one of the first diseases in which stem cells were used for regenerative medicine. Since 2001, many publications have shown that stem cell therapy has the potential to mitigate heart diseases, but there is no solid scientific evidence to fully support its clinical application at present. The future of regenerative medicine requires validated clinical trials with standardized platforms and transdisciplinary efforts to enable the development of safe and effective regenerative therapies to protect patients and to promote the ethical application of this new and highly promising therapy. Doctors and scientists have a responsibility to discuss with patients the current reality of regenerative therapies. They also have a responsibility to discourage the indiscriminate and commercial use of these therapies, which are sometimes based on false hopes, since their inappropriate use can harm vulnerable patients as well as research efforts. Although regenerative medicine may be the medicine of the future and might bring the hope of cure for chronic diseases, it is not yet ready for its wide clinical application.es-ES
dc.descriptionHeart failure is one of the first diseases in which stem cells were used for regenerative medicine. Since 2001, many publications have shown that stem cell therapy has the potential to mitigate heart diseases, but there is no solid scientific evidence to fully support its clinical application at present. The future of regenerative medicine requires validated clinical trials with standardized platforms and transdisciplinary efforts to enable the development of safe and effective regenerative therapies to protect patients and to promote the ethical application of this new and highly promising therapy. Doctors and scientists have a responsibility to discuss with patients the current reality of regenerative therapies. They also have a responsibility to discourage the indiscriminate and commercial use of these therapies, which are sometimes based on false hopes, since their inappropriate use can harm vulnerable patients as well as research efforts. Although regenerative medicine may be the medicine of the future and might bring the hope of cure for chronic diseases, it is not yet ready for its wide clinical application.en-US
dc.formatapplication/pdf
dc.languagespa
dc.publisherRevista Médica de Chilees-ES
dc.relationhttp://www.revistamedicadechile.cl/ojs/index.php/rmedica/article/view/7497/5011
dc.relationhttp://www.revistamedicadechile.cl/ojs/index.php/rmedica/article/downloadSuppFile/7497/40188
dc.relationhttp://www.revistamedicadechile.cl/ojs/index.php/rmedica/article/downloadSuppFile/7497/40189
dc.relationhttp://www.revistamedicadechile.cl/ojs/index.php/rmedica/article/downloadSuppFile/7497/40190
dc.relationhttp://www.revistamedicadechile.cl/ojs/index.php/rmedica/article/downloadSuppFile/7497/40641
dc.relationhttp://www.revistamedicadechile.cl/ojs/index.php/rmedica/article/downloadSuppFile/7497/41732
dc.relationhttp://www.revistamedicadechile.cl/ojs/index.php/rmedica/article/downloadSuppFile/7497/41733
dc.sourceRevista Médica de Chile; Vol. 147, núm. 6 (2019): JUNIO 2019es-ES
dc.source0034-9887
dc.subjectCell-and Tissue-Based Therapy; Heart Failure; Regenerative Medicine; Stem Cellses-ES
dc.subjectCell-and Tissue-Based Therapy; Heart Failure; Regenerative Medicine; Stem Cellsen-US
dc.titleTerapia con células madre e insuficiencia cardiaca: aspectos éticos.es-ES
dc.titleETHICS OF STEM CELL THERAPY FOR HEART FAILUREen-US
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion
dc.typeen-US
dc.typePUNTO DE VISTAes-ES


This item appears in the following Collection(s)

Show simple item record